The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors

NCT04768868 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: IMP7068

Sponsor

Impact Therapeutics, Inc.

Collaborators

[object Object]